research and development
Immunovia, Proteomedix to Collaborate on R&D Efforts
The strategic partnership is intended to increase both companies' research and development productivity and efficiency.
Early work will focus on making Catalog's chemistries work in smaller volumes with Seagate's lab-on-a-chip technology, with a goal of femtoliter droplets.
Ultima Genomics, Regeneron Pharmaceuticals Ink Development Agreement
Regeneron is already part of the early-access program for Ultima's forthcoming UG100 sequencer and will invest an undisclosed amount in Ultima.
The so-called Max Read flow cell could accommodate up to 1 billion reads, lowering costs for applications that require sequence reads shorter than 100 bp.
Invitae will no longer make payments during the R&D phase of the collaboration and instead will pay a higher price on the instrument and consumables later on.
May 26, 2021
Nov 23, 2020
Oct 14, 2020
Oct 8, 2020